Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)-Reference-Cited by-同舟云学术

Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)

Published:2017-04-08 Issue:4 Volume:25 Page:451-458
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Ghadian Alireza,Rezaei Mehran

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/article/10.1007/s10787-017-0343-2/fulltext.html

Reference27 articles.

1. Aggarwal S, Thareja S, Verma A, Bhardwaj TR, Kumar M (2010) An overview on 5α -reductase inhibitors. Steroids 75:109–153

2. Calder PC (2010) Omega-3 fatty acids and inflammatory processes. Nutrients 2:355–374

3. Carraro JC, Raynaud JP, Kock G, Chisolm GD, Di Silverio F, Teillac P (1996) Comparison of phytotherapy (Permixon) with finasteride in the treatment of BPH: a randomized international study of 1098 patients. Prostate 29:231–240

4. Chughtai B, Lee R, Te A, Kaplan S (2011) Role of Inflammation in benign prostatic hyperplasia. Rev Urol 13(3):147–150

5. De Marzo AM, Marchi VL, Epstein JI (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am Pathol 155:1985–1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia;Chinese Journal of Integrative Medicine;2024-08-27

2. IN SILICO ASSESSMENT OF AMELIORATIVE EFFECTS OF POLYUNSATURATED FATTY ACID (PUFAS) FROM NAVICULA SALINICOLA AS AN INHIBITOR OF BENIGN PROSTATE HYPERPLASIA;International Journal of Applied Pharmaceutics;2023-12-18

3. The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis;Translational Andrology and Urology;2022-03

4. Nutritional supplementation of the pharmacotherapy of prostate diseases;Research Results in Pharmacology;2021-07-07

5. The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigens (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis;Central European Journal of Urology;2021